Stock screenerAll disclosures →
EDGAR →
TSHA
Conviction 61HealthcareScan · Mon, Aug 10, 2026TSHA$6.38-2.82%
ResistanceSupportVol 14Insider sellVol MA14 2.51M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price6.38
Change-2.82%
Gap-3.96%
Rel volume1.40×
Avg volume2.76M
Avg $ vol16.39M
SMA 205.91
SMA 506.04
SMA 2005.29
Price vs 50+5.62%
Price vs 200+20.49%
MA stackbullish
50/200 cross—
Supertrenddown · 6.77
RSI (14)56
MACD hist0.10
MACD crossbull · 5d
Stoch %K / %D84 / 89
ADX (14)14
+DI / −DI21 / 15
RSI divergence—
MACD divergenceBullish
ATR %+5.85%
ADR %6.40%
52w high6.98
52w low2.72
From 52w high-8.67%
Above 52w low+134.37%
New 52w highNo
SqueezeOff
Bollinger width22.34%
%B0.85
Donchian pos83.59%
Donchian high6.59
Donchian low5.28
AVWAP (52w high)6.11
vs AVWAP high+4.31%
AVWAP (52w low)4.83
vs AVWAP low+32.06%
OBV trendFlat
Chaikin MF (20)0.17
Today vs 20d1.40×
Avg vol (14d)2.51M
Avg vol (20d)2.76M
Avg $ vol (20d)16.39M
Market cap—
RS 3m (vs SPY)-7.35%
RS 6m (vs SPY)+34.64%
RS line new highNo
Trend template7/8
Technical rank81.8
1 week+10.29%
1 month+0.55%
3 months-6.39%
6 months+38.29%
1 year+126.87%
YTD+21.43%
P/E-17.28
P/B8.89
P/S192.74
P/FCF-20.08
EPS-0.3400
Div yield—
ROE-51.43%
ROA-36.29%
Debt/Eq0.23
Current14.04
EV/EBITDA—
Gross margin—
Net margin—
Rev growth17.28%
EPS growth-22.06%
Price target12.50
Target upside90.69%
Analyst ratingBuy
Institutional91.15%
Ent. value1.66B
Revenue0
Net income-42.41M
Gross profit—
Free cash flow-93.83M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out287.36M
Employees99
ListedThu, Sep 24, 2020
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction61 / 100
Pattern quality—
Tech rank81.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.09
Support5.30
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TSHA
No recent disclosed trades by Congress in TSHA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TSHA · 8 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Nagendran Sukumar President and Head of R&D · Common Stock · 2026-07-10 | Sell | 200K | $1.2M | 2026-07-10 | 2026-07-10 |
Stalfort John A III Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Donenberg Phillip B. Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Stalfort John A III Director · Common Stock · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-02 |
Long Alison S Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Long Alison S Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Stalfort John A III Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
Sepp-Lorenzino Laura Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Donenberg Phillip B. Director · Common Stock · 2026-06-01 | Grant | 21.34K | $0 | 2026-06-01 | 2026-06-02 |
Sepp-Lorenzino Laura Director · Stock Option (right to buy) · 2026-06-01 | Grant | 42.67K | $0 | 2026-06-01 | 2026-06-02 |
SEC filings
EDGAR filings in TSHA · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.